• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Elizabeth Stringer Explains Veterans' Risk of Opioid Abuse

Video

What we found in our predictive model for opioid use disorder is that behavioral health conditions are actually the best predictors of who is going to traverse into opioid use disorder, explained Elizabeth Stringer, PhD, chief science and clinical officer of axialHealthcare.

What we found in our predictive model for opioid use disorder is that behavioral health conditions are actually the best predictors of who is going to traverse into opioid use disorder, explained Elizabeth Stringer, PhD, chief science and clinical officer of axialHealthcare.

Transcript:

Are veterans at a higher risk of opioid abuse than other demographics, and if so, why?

The VA [Veterans Administration] has been a great partner and a lot of wonderful research has come out of the VA when it comes to pain management and opioid use disorder. The military population is at increased risk— more than the general population– of traversing into opioid use disorder.

One of the reasons for that is, of course, the stress and exposure to things that most everyday Americans aren’t exposed to. What we found in our predictive model for opioid use disorder is that behavioral health conditions are actually the best predictors of who is going to traverse into opioid use disorder— who’s going to get diagnosed with opioid use disorder.

The military population has a high percentage of their population that have stress disorders, post-traumatic stress disorders, anxiety, and oftentimes depression. So, it’s typically around the behavioral health aspects that make this population vulnerable. Pain and opioid use disorder are both biopsychosocial conditions, so it’s not just the bio part or the behavioral health part, but also the social part too.

Unfortunately, as a society, we don’t always do a great job of socially supporting our veterans as they come back to America. Again, the sort of social component makes them more vulnerable to traversing into opioid use disorder.

Related Videos
Jawad Haider Butt, MD, PhD
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Andrew Kuykendall, MD, Moffitt Cancer Center
Anna Mueller, MD, Mount Sinai
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.